
Market Update by Liontrust – Q2 2020
Review of the High Yield Market in the second quarter of 2020 & outlook for the High Yield Market as the year continues.
Review of the High Yield Market in the second quarter of 2020 & outlook for the High Yield Market as the year continues.
Many are speculating that companies, now at bargain basement prices, should recover to their pre-Covid levels and therefore represent extraordinary value for investors. Stephen Yiu outlines three types of companies that he thinks are best left alone for the time being.
In light of the recent Covid-19 related market sell-off, Stephen Yiu answered questions from investors about actions taken at a fund level and the fund’s positioning going forwards.
With rising concerns about cancelled and suspended dividends from equities, high-quality high yield bonds can replace any missing income stream without taking on excessive risk as the world navigates the economic fallout from Covid-19.
Review of the High Yield Market in the first quarter of 2020 & outlook for the High Yield Market as the year continues.
Donald Philips discusses the market in the current situation, and how Liontrust have positioned themselves during this time of considerable uncertainty. He explains how they view current valuations as an opportunity for the medium to long-term investors.
Stephen Yiu discusses the COVID-19 sell-off, what it means for investors, and how Blue Whale Growth Fund is positioned during this time of considerable uncertainty. Have we seen the worst of it? Where do we stand now?
Review of the High Yield Market in the third quarter of 2019 & outlook for the High Yield Market as the year continues.
Review of the High Yield Market in the third quarter of 2019 & outlook for the High Yield Market as the year continues.
Review of the High Yield Market in the second quarter of 2019 & outlook for the High Yield Market as the year continues.
The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. Sign up and open your account for free, within minutes.
You are leaving medirect.com.mt
Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.
Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.
We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.
For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.